Calithera Biosciences (NASDAQ:CALA) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of Calithera Biosciences (NASDAQ:CALAFree Report) in a report issued on Sunday morning. The brokerage issued a hold rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

NASDAQ CALA opened at $0.02 on Friday. Calithera Biosciences has a 52-week low of $0.01 and a 52-week high of $0.50. The company has a fifty day moving average of $0.02 and a 200-day moving average of $0.03.

Calithera Biosciences Company Profile

(Get Free Report)

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.

Featured Articles

Receive News & Ratings for Calithera Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Calithera Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.